TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18931227

Group type: EXPERIMENTAL
Intervention: Dural puncture with a 25‐gauge Whitacre spinal needle before epidural analgesia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard epidural technique without prior dural puncture
Number of subjects: 80
Study: 15979283

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (group I)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control subjects with eutrophia (group II)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Patients with other illnesses but normal digestive tracts (group III)
Number of subjects: 27
Study: 11936545

Group type: EXPERIMENTAL
Intervention: Actual items presentation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Pictures of the items presentation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Spoken-name presentation
Number of subjects: 9
Study: 10411194

Group type: EXPERIMENTAL
Intervention: Intranasally administered trivalent LAIV vaccine
Number of subjects: 4561

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4561
Study: 7574055

Group type: EXPERIMENTAL
Intervention: Group B (preoperative bolus of bupivacaine followed by an infusion of bupivacaine)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Group MB (preoperative bolus of epidural bupivacaine and morphine followed by an infusion of morphine and bupivacaine)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Group M (preoperative bolus of epidural morphine followed by an infusion of morphine)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Group P (preoperative bolus of intravenous morphine followed by intravenous patient‐controlled morphine postoperatively)
Number of subjects: 54
Study: 1309127

Group type: EXPERIMENTAL
Intervention: Assisted hatching by zona drilling using acidic Tyrode's solution on embryos with thick zonae (> 15 microns).
Number of subjects: 330

Group type: COMPARATOR
Intervention: Assisted hatching by zona drilling using acidic Tyrode's solution on embryos with thin zonae (< 13 microns).
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control group with embryos having thin zonae left intact.
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Assisted hatching with removal of small amounts of fragments from embryos during assisted hatching.
Number of subjects: 330
Study: 6532286

Group type: EXPERIMENTAL
Intervention: 1% indomethacin ophthalmic solution
Number of subjects: 106

Group type: COMPARATOR
Intervention: Routine preoperative dilating drops (Control)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 106
Study: 30316548

Group type: EXPERIMENTAL
Intervention: Eight-week pulmonary rehabilitation program (home or hospital)
Number of subjects: 166
Study: 29443739

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 60
Study: 26963847

Group type: EXPERIMENTAL
Intervention: Tailored activity pacing
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: General activity pacing
Number of subjects: 193

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 193
Study: 25107318

Group type: EXPERIMENTAL
Intervention: Problem Solving Therapy‐Primary Care (PST‐PC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dietary Education (DIET)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PST‐PC
Number of subjects: 60

Group type: COMPARATOR
Intervention: DIET
Number of subjects: 60
Study: 22644259

Group type: EXPERIMENTAL
Intervention: Experimental group (EG) using EORTC QLQ‐C30 + LC13 questionnaire via digital table interface
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Experimental group (EG)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group (CG) using paper version of EORTC QLQ‐C30 + LC13 questionnaire
Number of subjects: 171
Study: 21392377

Group type: EXPERIMENTAL
Intervention: Five years of OPUS treatment
Number of subjects: 400

Group type: COMPARATOR
Intervention: Two years of OPUS treatment
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 400
Study: 19255201

Group type: EXPERIMENTAL
Intervention: Circular external fixation
Number of subjects: 82

Group type: COMPARATOR
Intervention: Open reduction and internal fixation
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 82
Study: 16969747

Group type: EXPERIMENTAL
Intervention: Polymethylmethacrylate (PMMA)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Titanium cage
Number of subjects: 107
Study: 15088880

Group type: EXPERIMENTAL
Intervention: Coronally positioned flap + subepithelial connective tissue graft (CPF + SCTG)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Coronally positioned flap alone (CPF)
Number of subjects: 11
Study: 11248153

Group type: EXPERIMENTAL
Intervention: Standard chemotherapy plus trastuzumab
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Anthracycline and cyclophosphamide plus trastuzumab
Number of subjects: 469

Group type: COMPARATOR
Intervention: Anthracycline and cyclophosphamide alone
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus trastuzumab
Number of subjects: 469

Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 469
Study: 9579879

Group type: EXPERIMENTAL
Intervention: rhEPO (5x500 U/kg body weight) + oral Fe2+ (300 mg/day)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo + oral Fe2+ (300 mg/day)
Number of subjects: 76
Study: 7538400

Group type: EXPERIMENTAL
Intervention: Prolase II fiber (cytocare) treatment for BPH
Number of subjects: 15

Group type: COMPARATOR
Intervention: TURP (Transurethral Resection of the Prostate)
Number of subjects: 15
Study: 2406326

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 3.5 gm/day for 8 weeks
Number of subjects: 7

Group type: COMPARATOR
Intervention: Diluent alone (control)
Number of subjects: 7
Study: 6797732

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) ointment, 7.5 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Propranolol (P), 20-40 mg, 3 times daily
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nifedipine (N), 10 mg, 3-4 times daily
Number of subjects: 21
Study: 31870556

Group type: EXPERIMENTAL
Intervention: Combination of pimasertib (60 mg daily) + SAR245409 (70 mg daily)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Pimasertib alone (60 mg BID)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Combination of pimasertib + SAR245409
Number of subjects: 65
Study: 31487422

Group type: EXPERIMENTAL
Intervention: GA plus endoscopic SPGB
Number of subjects: 60

Group type: COMPARATOR
Intervention: GA alone (control)
Number of subjects: 60
Study: 28891320

Group type: EXPERIMENTAL
Intervention: Nephrostomy tube (Group 1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Double‐J (JJ) stent (Group 2)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Open‐ended ureteral catheter (Group 3)
Number of subjects: 90
Study: 26242218

Group type: EXPERIMENTAL
Intervention: Habit-based intervention to reduce sedentary behaviour
Number of subjects: 23
Study: 24095610

Group type: EXPERIMENTAL
Intervention: Taxane-based regimen
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Taxane-based regimen with clinical variables
Number of subjects: 153
Study: 21298288

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with Chinese herbal medicine (Kangliuzengxiao decoction during chemotherapy and Feiyanning decoction after chemotherapy)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 121
Study: 19705245

Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 16 mg dexamethasone
Number of subjects: 36
Study: 17576774

Group type: EXPERIMENTAL
Intervention: Culturally targeted materials
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard care materials
Number of subjects: 500
Study: 15514373

Group type: EXPERIMENTAL
Intervention: LV5FU2 (Leucovorin 200 mg/m2 + Fluorouracil 400 mg/m2 bolus + Fluorouracil 600 mg/m2 continuous infusion)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: LV5FU2 plus cisplatin (50 mg/m2)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: LV5FU2 plus irinotecan (180 mg/m2)
Number of subjects: 134
Study: 11694773

Group type: EXPERIMENTAL
Intervention: Concurrent schedule of short-infusion IFO at total dose of 7.5-9 g/m² over 5 days plus iv bolus EPI at 90-120 mg/m²/cycle, repeated every 3 weeks (group A)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sequential schedule of dose-intense, continuous infusion IFO at a total dose of 14-18 g/m² for 2 cycles followed by bimonthly EPI at 120-160 mg/m²/cycle (group B)
Number of subjects: 44
Study: 9745107

Group type: EXPERIMENTAL
Intervention: Oat milk
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Soya milk
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oat milk, soya milk, cow's milk (combined)
Number of subjects: 24
Study: 7880993

Group type: EXPERIMENTAL
Intervention: fentanyl/alpha‐stat
Number of subjects: 32

Group type: COMPARATOR
Intervention: fentanyl/pH‐stat
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: sufentanil/alpha‐stat
Number of subjects: 32

Group type: COMPARATOR
Intervention: sufentanil/pH‐stat
Number of subjects: 32
Study: 1979083

Group type: EXPERIMENTAL
Intervention: LongoVital (LV)
Number of subjects: 31
Study: 762958

Group type: EXPERIMENTAL
Intervention: High potassium cardioplegic solution (20 mEq. per liter)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low potassium cardioplegic solution (5 mEq. per liter)
Number of subjects: 50
Study: 31118371

Group type: EXPERIMENTAL
Intervention: 3 mg repaglinide per day (1 mg each time before meals) for 8 weeks
Number of subjects: 234

Group type: COMPARATOR
Intervention: ABCC8 rs1801261 allele frequency in T2DM patients
Number of subjects: 234
Study: 27593087

Group type: EXPERIMENTAL
Intervention: Digital Audio Recording (DAR) and Question Prompt List (QPL)
Number of subjects: 4349

Group type: EXPERIMENTAL
Intervention: Digital Audio Recording (DAR) only
Number of subjects: 4349

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 4349
Study: 25881022

Group type: EXPERIMENTAL
Intervention: 3 years of continued Specialized Early Intervention (SEI)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Regular care in the community
Number of subjects: 212
Study: 23410792

Group type: EXPERIMENTAL
Intervention: Doripenem
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparator agents
Number of subjects: 0
Study: 20674225

Group type: EXPERIMENTAL
Intervention: Amplified stethoscope (Littman 3100)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional stethoscope (Littman cardiology III)
Number of subjects: 32
Study: 18936867

Group type: EXPERIMENTAL
Intervention: Macroplastique(R) (MPQ) Implantation System (MIS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Pelvic floor muscle exercises home program
Number of subjects: 45
Study: 17041001

Group type: EXPERIMENTAL
Intervention: Risedronate 2.5 mg/day (group R)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Alfacalcidol 0.5 mug/day (group A)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Combination of risedronate and alfacalcidol (group R+A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Risedronate (group R)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Alfacalcidol (group A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 38
Study: 17051709

Group type: EXPERIMENTAL
Intervention: Local hyperthermia using balloon-type electrodes in combination with standard chemo- and radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard chemo- and radiotherapy
Number of subjects: 0
Study: 11555746

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation combined with cognitive behavioral therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 19
Study: 9783297

Group type: EXPERIMENTAL
Intervention: Vitremer with primer (20 preps)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Vitremer without primer (19 preps)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Z100 with Scotchbond Multi‐Purpose (18 preps)
Number of subjects: 32
Study: 7929519

Group type: EXPERIMENTAL
Intervention: Synthetic donor site dressing
Number of subjects: 38

Group type: COMPARATOR
Intervention: Impregnated gauze dressing
Number of subjects: 38
Study: 3309480

Group type: EXPERIMENTAL
Intervention: Blood cardioplegia
Number of subjects: 103

Group type: COMPARATOR
Intervention: Crystalloid cardioplegia
Number of subjects: 103

Group type: COMPARATOR
Intervention: Diltiazem crystalloid cardioplegia
Number of subjects: 103
Study: 31985112

Group type: EXPERIMENTAL
Intervention: Melatonin 5 mg nightly for five nights
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 29858041

Group type: EXPERIMENTAL
Intervention: Decision support application
Number of subjects: 67

Group type: COMPARATOR
Intervention: Regular procedure without the App
Number of subjects: 67
Study: 26554378

Group type: EXPERIMENTAL
Intervention: Patients with OLP (case group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Comparison of secretor status between OLP patients and controls
Number of subjects: 30
Study: 25555358

Group type: EXPERIMENTAL
Intervention: Decision support tool with auditory and visual prompts
Number of subjects: 65

Group type: COMPARATOR
Intervention: Memory alone (control group)
Number of subjects: 65
Study: 23583817

Group type: EXPERIMENTAL
Intervention: PVRV administered intramuscularly (1 ml)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PVRV administered intradermally (0.1 ml)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Commercially available PVRV (Verorab) administered intramuscularly
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 60
Study: 21958773

Group type: EXPERIMENTAL
Intervention: Statin therapy targeting LDL levels less than 100 mg/dL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statin therapy targeting LDL levels less than 70 mg/dL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consistent statin use throughout the trial period
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients with LDL levels >100 mg/dL
Number of subjects: 0
Study: 18559235

Group type: EXPERIMENTAL
Intervention: Qinzhu Liangxue Decoction (QZLXD)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Ampeptide
Number of subjects: 58
Study: 16385088

Group type: EXPERIMENTAL
Intervention: Aspirin at 150 to 200 mg per day
Number of subjects: 871

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 871
Study: 14666440

Group type: EXPERIMENTAL
Intervention: Clonidine 5 microg x kg(‐1) (group HD)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Clonidine 2 microg x kg(‐1) (group ND)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg x kg(‐1) (group midazolam)
Number of subjects: 45
Study: 10971792

Group type: EXPERIMENTAL
Intervention: orlistat 120 mg three times daily
Number of subjects: 376
Study: 8782006

Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic acid (10 mg kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (10 mg kg‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1616093

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate spray (30 s before induction)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate spray (90 s before induction)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo buccal spray (90 s before induction)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 6379142

Group type: EXPERIMENTAL
Intervention: High sugar diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low sugar diet
Number of subjects: 20
Study: 31209448

Group type: EXPERIMENTAL
Intervention: Carisolv
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Papacârie
Number of subjects: 32

Group type: COMPARATOR
Intervention: Mechanical excavation (hand excavator)
Number of subjects: 32
Study: 29280726

Group type: EXPERIMENTAL
Intervention: Strategy training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 30
Study: 27430256

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg BID for 12 months
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 150
Study: 25033153

Group type: EXPERIMENTAL
Intervention: Scattered-site public housing
Number of subjects: 453

Group type: COMPARATOR
Intervention: Clustered public housing
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: More network members who smoked
Number of subjects: 453
Study: 22156234

Group type: EXPERIMENTAL
Intervention: Parental component intervention (n = 1226)
Number of subjects: 2232

Group type: COMPARATOR
Intervention: No parental component intervention (n = 1006)
Number of subjects: 2232
Study: 19154859

Group type: EXPERIMENTAL
Intervention: Spiritual mantram intervention
Number of subjects: 71

Group type: COMPARATOR
Intervention: Attention-matched control group
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 71
Study: 17135183

Group type: EXPERIMENTAL
Intervention: Ceftriaxone administered by 24 h continuous infusion
Number of subjects: 57

Group type: COMPARATOR
Intervention: Ceftriaxone administered by once‐daily intermittent bolus dosing
Number of subjects: 57
Study: 16266472

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg per day)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Indapamide (2.5 mg per day)
Number of subjects: 105
Study: 12412696

Group type: EXPERIMENTAL
Intervention: Talcage (TT)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Pleural Drainage (PD)
Number of subjects: 108
Study: 10374624

Group type: EXPERIMENTAL
Intervention: Clenbuterol 60 micrograms Bid for more than 3 months
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 7889440

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) at doses of 80 to 1300 mg (Part 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Chronic dose of ASA (325 mg) (Part 2)
Number of subjects: 50

Group type: COMPARATOR
Intervention: ASA nonresponders (Part 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: ASA nonresponders (Part 2)
Number of subjects: 50
Study: 2228924

Group type: EXPERIMENTAL
Intervention: Methylphenidate treatment during double-blind trials
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Methylphenidate treatment
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 657455

Group type: EXPERIMENTAL
Intervention: Oral sodium (100 mEq) with 200ml of 5% dextrose in water intravenously
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intravenous sodium (100 mEq) with placebo capsules orally
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral sodium (50 mEq) in patients with primary adrenocortical insufficiency
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intravenous sodium (50 mEq) in patients with primary adrenocortical insufficiency
Number of subjects: 8
Study: 30298281

Group type: EXPERIMENTAL
Intervention: Sustained elevation of postoperative serum CA19-9 levels (Group E, n = 159)
Number of subjects: 539

Group type: COMPARATOR
Intervention: No elevation of postoperative serum CA19-9 levels (Group N, n = 380)
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Sustained elevation of postoperative serum CA19-9 levels (Group E)
Number of subjects: 539

Group type: COMPARATOR
Intervention: No elevation of postoperative serum CA19-9 levels (Group N)
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Postoperative CA19-9 elevation
Number of subjects: 539
Study: 28276510

Group type: EXPERIMENTAL
Intervention: Social observation during the ultimatum game (UG)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No social observation during the ultimatum game (UG)
Number of subjects: 32
Study: 26037286

Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs) in addition to antiplatelet therapy
Number of subjects: 46782

Group type: EXPERIMENTAL
Intervention: PAR-1 antagonists in addition to antiplatelet therapy
Number of subjects: 46782

Group type: COMPARATOR
Intervention: Antiplatelet therapy alone
Number of subjects: 46782
Study: 23515265

Group type: EXPERIMENTAL
Intervention: Daily median estimated pulmonary artery diastolic pressures (ePAD)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Average median ePAD calculated over the whole follow-up period
Number of subjects: 378
Study: 21757376

Group type: EXPERIMENTAL
Intervention: GIN therapy (high-dose insulin at 5 mU/kg/min during surgery)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: GIN therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (insulin on a sliding scale aiming at normoglycemia)
Number of subjects: 40
Study: 19539104

Group type: EXPERIMENTAL
Intervention: Test formulation of alendronate sodium 70 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Reference formulation of alendronate sodium 70 mg
Number of subjects: 23
Study: 17603694

Group type: EXPERIMENTAL
Intervention: Low power radiofrequency electromagnetic radiation (RF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 40
Study: 15193907

Group type: EXPERIMENTAL
Intervention: Peeled sweeties supplemented diet (EG1)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Peeled sweeties supplemented diet (EG2)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 66
Study: 11405503

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control (no thrombolytic therapy)
Number of subjects: 74
Study: 9989882

Group type: EXPERIMENTAL
Intervention: Peripheral blood stem cell (PBSC) collection with mobilising chemotherapy (cyclophosphamide, etoposide, doxorubicin, cytosine arabinoside) and G-CSF, total of 47 courses.
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with autologous stem cell rescue (21 of 37 patients).
Number of subjects: 37

Group type: COMPARATOR
Intervention: PBSC group compared to historical group of ABMT patients.
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Overall survival of patients after PBSC collection.
Number of subjects: 37
Study: 7539806

Group type: EXPERIMENTAL
Intervention: Aprotinin (6,000,000 KIE)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100